On Thursday, South Korea’s antitrust regulator gave approval for UBS Group to acquire Credit Suisse Group, stating that the merger is unlikely to have an impact on competition in the local market.
Overseas companies that make sales of 30 billion won in South Korea are required to report their mergers to the regulator. UBS and Credit Suisse, two companies based in Switzerland, have been reviewed in accordance with this regulation.
The Fair Trade Commission (KFTC) released a statement stating that, after reviewing the process, they have determined that the move is unlikely to limit competition in the market for all types of mergers.
Related: EU Set To OK UBS-Credit Suisse Deal
The KFTC conducted an investigation on the effects of vertical and horizontal mergers in various industries including brokerage, acquisition advisory, debt capital market, and asset management.
“All four areas where the horizontal merger is set to occur are already participated in by numerous players that engage in intense competition,” the KFTC said. “Even after the merger, UBS and Credit Suisse are not likely to raise prices, as their shares are small.”
The regulator noted that the two investment banks lack significant market presence in South Korea, which does not disrupt the operations of other competitors.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI